Back to Journals » Breast Cancer: Targets and Therapy
Breast Cancer: Targets and Therapy
Editor-in-Chief: Professor Pranela Rameshwar
Breast Cancer: Targets and Therapy is an international, peer reviewed, open access journal focusing on breast cancer, basic and translational research, clinical trials and treatment. The latter includes outcome studies that incorporate preventative and integrated treatment strategies for enhanced survival, and quality of life for cancer patients.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
This journal offers Accelerated Publication.
Articles:
- View all (746)
- Volume 18, 2026 (95)
- Volume 17, 2025 (104)
- Volume 16, 2024 (76)
- Volume 15, 2023 (79)
- Volume 14, 2022 (41)
- Volume 13, 2021 (58)
- Volume 12, 2020 (27)
- Volume 11, 2019 (32)
- Volume 10, 2018 (24)
- Volume 9, 2017 (64)
- Volume 8, 2016 (26)
- Volume 7, 2015 (36)
- Volume 6, 2014 (20)
- Volume 5, 2013 (13)
- Volume 4, 2012 (22)
- Volume 3, 2011 (16)
- Volume 2, 2010 (9)
- Volume 1, 2009 (4)
Latest articles:
- 5 records -
Exosomal miR-21 Derived from Paclitaxel-Resistant Breast Cancer Cells Promotes Chemoresistance in Breast Cancer via p53/PI3K/AKT/mTOR Signaling
Wang Y, Cai Q
Breast Cancer: Targets and Therapy 2026, 18:615413
Published Date: 27 July 2026
Integrative Network-Based Transcriptomic Analysis Identifies Niclosamide as a Candidate Repositioned Drug for Breast Cancer
Aydin B, Okutan BN, Sara FE, Gulseren G, Sinha R
Breast Cancer: Targets and Therapy 2026, 18:606551
Published Date: 24 July 2026
Long Non-Coding RNA PVT1 Promotes Doxorubicin Resistance by Inhibiting Ferroptosis in Breast Cancer
Zhao D, Tan Z, Chen W, Liu S, Wu T, Li X, Xiang Y, Wang H, Lu Z
Breast Cancer: Targets and Therapy 2026, 18:583235
Published Date: 24 July 2026
miR-1911-3p Regulates Malignant Biological Behaviors and Glycolytic Activity of Triple-Negative Breast Cancer via FBLN5
Kong L, Zhang H, Sui X, Peng X, Sun T
Breast Cancer: Targets and Therapy 2026, 18:615715
Published Date: 23 July 2026
Estrogen-Driven Breast Carcinogenesis in a Rat Model is Linked to Retroelement Activation and Inflammation and is Susceptible to Lamivudine Treatment
Evdokimova V, Zhang Z, Ruzanov P, Hung M, Khoshgoo N, Zheng S, Quintayo MA, Stein LD, Bayani J, Radvanyi L
Breast Cancer: Targets and Therapy 2026, 18:608709
Published Date: 23 July 2026